ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

AUTL Autolus Therapeutics PLC

4.00
0.00 (0.00%)
プレマーケット
最終更新日: 18:31:14
15分遅延
名称 銘柄コード 市場 種別
Autolus Therapeutics PLC AUTL NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.00 18:31:14
始値 安値 高値 終値 前日終値
4.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2423:00GLOBEAbstract for longer-term follow-up and additional data..
2024/4/2320:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
2024/4/0220:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
2024/4/0120:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
2024/3/1420:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
2024/3/1220:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
2024/3/1120:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
2024/2/2921:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
2024/2/2407:28EDGAR2Form D - Notice of Exempt Offering of Securities
2024/2/2221:00GLOBEAutolus Therapeutics announces publication in Nature..
2024/2/2207:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2024/2/1422:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1007:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0906:17EDGAR2Form 8-K - Current report
2024/2/0821:00GLOBEAutolus Announces Pricing of Underwritten Offering
2024/2/0820:06EDGAR2Form 8-K - Current report
2024/2/0819:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
2024/2/0812:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/0106:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2703:02EDGAR2Form 8-K - Current report
2024/1/2321:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
2024/1/2221:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
2024/1/2221:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
2024/1/1105:12EDGAR2Form 8-K - Current report
2024/1/1021:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
2023/12/2222:24EDGAR2Form 8-K - Current report
2023/12/2221:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
2023/12/1122:31EDGAR2Form 8-K - Current report
2023/12/1010:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
2023/11/2904:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
2023/11/2721:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
2023/11/2721:07EDGAR2Form 8-K - Current report
2023/11/2721:00GLOBEAutolus Therapeutics Submits Biologics License Application..
2023/11/1521:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
2023/11/1006:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0923:18EDGAR2Form 8-K - Current report
2023/11/0621:00GLOBEAutolus Therapeutics announces participation in upcoming..
2023/11/0405:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/0305:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0222:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
2023/11/0220:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
2023/10/1720:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
2023/10/1121:07GLOBECorrection - Autolus Therapeutics to report third quarter..
2023/10/1120:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
2023/9/0520:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
2023/8/0805:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0405:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0320:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
2023/7/2205:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/1820:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..

最近閲覧した銘柄

Delayed Upgrade Clock